FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21017811000001107: Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Aug 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70099101000001111 Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70099201000001116 Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has VMP Magnesium glycerophosphate 97.2mg (magnesium 4mmol) chewable tablets sugar free true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mag-4 (magnesium 97.2mg (4mmol)) chewable tablets (Ennogen Healthcare Ltd) 30 tablet Is a True Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets sugar free 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start